Shared decision-making for biologic treatment of autoimmune disease: Influence on adherence, persistence, satisfaction, and health care costs

Patient Preference and Adherence

Volumn 11, Issue , 2017, Pages 947-958

  Lofland, Jennifer H ^a   Johnson, Phaedra T ^b   Ingham, Mike P ^c   Rosemas, Sarah C ^b   White, John C ^b   Ellis, Lorie ^c  

^a JOHNSON AND JOHNSON   (United States)

^b OPTUM   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Autoimmune disease; Biologic therapy; Cross sectional survey; Shared decision making

Indexed keywords

ABATACEPT; ADALIMUMAB; ANAKINRA; CERTOLIZUMAB PEGOL; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; NATALIZUMAB; RITUXIMAB; TOCILIZUMAB; USTEKINUMAB;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BIOLOGICAL THERAPY; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DRUG CHOICE; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MORISKY MEDICATION ADHERENCE SCALE; OBSERVATIONAL STUDY; PATIENT ACTIVATION MEASURE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PATIENT SATISFACTION; PATIENT-REPORTED OUTCOME; PSORIATIC ARTHRITIS; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SELF INJECTION; SHARED DECISION MAKING; SHARED DECISION MAKING QUESTIONNAIRE; ULCERATIVE COLITIS;

EID: 85020450528     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S133222     Document Type: Article

References (35)

1. Shafir A, Rosenthal J. Shared Decision Making: Advancing Patient-Centered Care through State and Federal Implementation. Washington, DC: National Academy for State Health Policy; 2012. Available from: http://www.nashp.org/sites/default/files/shared.decision.making.report.pdf. Accessed January 24, 2017.
2. Department of Health and Human Services. National Strategy for Quality Improvement in Health Care: Agency-specific Quality Strategic Plans. Bethesda, MD: DHHS; 2011. Available from: https://www.ahrq.gov/workingforquality/nqs/nqsplans.pdf. Accessed January 24, 2017.
3. Elwyn G, Lloyd A, May C, et al. Collaborative deliberation: a model for patient care. Patient Educ Couns. 2014;97(2):158-164.
4. Elwyn G, Frosch D, Thomson R, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361-1367.
5. Umar N, Litaker D, Schaarschmidt M-L, et al. Outcomes associated with matching patients’ treatment preferences to physicians recommendations: study methodology. BMC Health Serv Res. 2012;12:1.
6. Oshima Lee E, Emanuel EJ. Shared decision making to improve care and reduce costs. N Engl J Med. 2013;368(1):6-8.
7. Arterburn D, Wellman R, Westbrook E, et al. Introducing decision aids at Group Health was linked to sharply lower hip and knee surgery rates and costs. Health Aff. 2012;31(9):2094-2104.
8. Kriston L, Scholl I, Hölzel L, Simon D, Loh A, Härter M. The 9-item Shared Decision Making Questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample. Patient Educ Couns. 2010;80(1):94-99.
9. Giersdorf N, Loh A, Bieber C, et al; Arbeitsgruppe Methoden des BMGS-Förderschwerpunktes Der Patient als Partner im medizinischen Entscheidungsprozess. Development and validation of assessment instruments for shared decision making. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004;47(10):969-976. [German].
10. Simon D, Schorr G, Wirtz M, et al. Development and first validation of the shared decision-making questionnaire (SDM-Q). Patient Educ Couns. 2006;63(3):319-327.
11. Simon D, Loh A, Harter M. Measuring (shared) decision-making - a review of psychometric instruments. Z Arztl Fortbild Qualitatssich. 2007;101(4):259-267.
12. Simon D, Loh A, Harter M. Die entwicklung und evaluation von interventionen zur förderung partizipativer entscheidungsfindung -rahmenkonzept und messinstrumente [Development and evaluation of interventions to support shared decision making - framework and measuring instruments]. Z Med Psychol. 2008;17:149-159. [German].
13. Zampeli E, Vlachoyiannopoulos PG, Tzioufas AG. Treatment of rheumatoid arthritis: unraveling the conundrum. J Autoimmun. 2015;65: 1-18.
14. Mease PJ. Biologic therapy for psoriatic arthritis. Rheum Dis Clin North Am. 2015;41(4):723-738.
15. Côté-Daigneault J, Bouin M, Lahaie R, Colombel JF, Poitras P. Biologics in inflammatory bowel disease: what are the data? United European Gastroenterol J. 2015;3(5):419-428.
16. Barton JL. Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy. Patient Prefer Adherence. 2009;3:335-344.
17. Baars JE, Markus T, Kuipers EJ, van der Woude CJ. Patients’ preferences regarding shared decision-making in the treatment of inflammatory bowel disease: results from a patient-empowerment study. Digestion. 2010;81(2):113-119.
18. Mathews AL, Coleska A, Burns PB, Chung KC. The evolution of patient decision-making regarding medical treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2016;68(3):318-324.
19. Conrad S, Hüppe A, Raspe H. Zu welchen themen wünschen patientinnen und patienten mit morbus crohn oder colitis ulcerosa mehr informationen und welche eigene rolle bevorzugen sie bei medizinischen behandlungsentscheidungen? Ergebnisse einer betroffenenbefragung in Deutschland [Preference of patients with inflammatory bowel disease regarding information and shared decision-making: results from a crosssectional survey in Germany]. Z Gastroenterol. 2012;50(4):364-372.
20. Nota I, Drossaert CH, Taal E, van de Laar MA. Arthritis patients’ motives for (not) wanting to be involved in medical decision-making and the factors that hinder or promote patient involvement. Clin Rheumatol. 2016;35(5):1225-1235.
21. Siegel CA, Lofland JH, Naim A, et al. Novel statistical approach to determine inflammatory bowel disease: patients’ perspectives on shared decision making. Patient. 2016;9(1):79089.
22. Renzi C, Di Pietro C, Tabolli S. Participation, satisfaction and knowledge level of patients with cutaneous psoriasis or psoriatic arthritis. Clin Exp Dermatol. 2011;36(8):885-888.
23. Barton JL, Trupin L, Tonner C, et al. English language proficiency, health literacy, and trust in physician are associated with shared decision-making in rheumatoid arthritis. J Rheumatol. 2014;41(7): 1290-1297.
24. Bewtra M, Johnson FR. Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data. Patient. 2013;6(4):241-255.
25. Lipstein EA, Dodds CM, Britto MT. Real life clinic visits do not match the ideals of shared decision making. J Pediatr. 2014;165(1):178-183.
26. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30(6):473-483.
27. Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res. 2005;40(6):1918-1930.
28. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
29. Morisky DE, Malotte CK, Choi P, et al. A patient education program to improve adherence rate with antituberculosis drug regimens. Health Educ Q. 1990;17(3):253-268.
30. Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: final response. J Clin Epidemiol. 2011;64: 258-263.
31. Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6): 676-682.
32. American Association for Public Opinion Research [webpage on the Internet]. Standard Definitions: Final Dispositions and Case Codes and Outcome Rates for Surveys. Deerfield, IL: AAPOR; 2008. Available from http://www.aapor.org/Standards-Ethics/Standard-Definitions-(1).aspx. Accessed January 24, 2017.
33. Munson GW, Wallston KA, Dittus RS, Speroff T, Roumie CL. Activation and perceived expectancies: correlations with health outcomes among veterans with inflammatory bowel disease. J Gen Intern Med. 2009; 24(7):809-815.
34. Hibbard JH, Greene J. What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff. 2013;32(2):207-214.
35. Greene J, Hibbard JH. Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med. 2012;27(5):520-526.